Investigators are seeking participants for an ongoing phase 2 clinical trial, sponsored by Cytokinetics, to test the investigational drug CK-2127107 in people with types 2, 3 or 4 SMA.
Researchers are looking for people with ALS and healthy volunteers to participate in the Microbiome Assessment in People with ALS (MAP ALS) study.
Excited to try MDA’s new web-based Clinical Trials Finder Tool powered by Antidote? Here are some questions we have received and answers that should make using the tool as seamless as possible.
Researchers are looking for people to participate in CReATe Consortium’s PGB study to help learn about ALS and related diseases.
Researchers are looking for 220 people with ALS and 30 people who do not have ALS from around the country to participate in the ALS At HOME study.
Vamorolone (formerly VBP15), under development by ReveraGen BioPharma, has received FDA Fast Track designation for the treatment of DMD.
Akashi Therapeutics announced that the FDA has cleared the way for the company to resume clinical development of HT-100 in boys with DMD.
Researchers are looking for people to participate in a clinical trial, sponsored by Cedars-Sinai Medical Center, to test the safety and efficacy of beetroot juice extract in people with BMD.
Researchers are looking for people to participate in a phase 2 clinical trial, sponsored by Neuraltus Pharmaceuticals, that is designed to test whether the investigational drug NP001 slows progression of signs and symptoms in ALS.
The Muscular Dystrophy Association is pleased to announce the award of a clinical research network grant totaling $918,000 over three years to spur advances in myotonic dystrophy (DM) research.
